Tech Company Financing Transactions
Scopio Labs Funding Round
Viola Growth and private investors participated in a $10 million Series D funding round for Scopio Labs. The round was announced on 7/25/2025.
Transaction Overview
Company Name
Announced On
7/25/2025
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series D
Investors
Viola Growth (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
10 Hasharon St.
Tel Aviv, Undisclosed
Israel
Tel Aviv, Undisclosed
Israel
Phone
Undisclosed
Website
Email Address
Overview
Scopio is changing the standard of healthcare and revolutionizing first-line diagnostic testing by harnessing the power of computational photography and AI to image and analyze the morphology of cells at a scale that was never possible before, expediting access to life-saving treatments and improved patient outcomes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Itai Hayut
Chief Scientific Officer
Iris Getz
Chief Technical Officer
Erez Na'aman
VP - Bus. Development
Amir Farhi
VP - Bus. Development
Jordan Feder
VP - Human Resources
Tali Cohen
VP - Marketing
Lianne Trantz
VP - Product Management
Amy Meitus
VP - R & D
Oren Harel
Browse more venture capital transactions:
Prev: 7/25/2025: Maro venture capital transaction
Next: 7/25/2025: Baxter Aerospace venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs